Search Within

Kenneth Seier

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (2)
Groups
  1. Bone Marrow Transplant (13)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Survivorship Research (13)
  6. Biostatistics Service (11)

More Groups

People
  1. Gunjan Shah (13)
  2. Sean Devlin (11)
  3. Sergio Giralt (10)
  4. Meighan Palazzo (8)
  5. Miguel-Angel Perales (8)
  6. Molly Maloy (8)

More People

Years
  1. 2024 (1)
  2. 2020 (1)
  3. 2019 (3)
  4. 2018 (5)
  5. 2017 (3)
Publications
  1. Biology of Blood and Marrow Transplantation (6)
  2. Blood (3)
  3. Bone Marrow Transplantation (2)
  4. Clinical Lymphoma, Myeloma and Leukemia (2)
Publishers
  1. Elsevier Inc. (8)
  2. American Society of Hematology (3)
  3. Nature Publishing Group (2)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation
    Journal Article

    Melica, G.; Preston, E.; Palazzo, M.; Seier, K.; Malard, F.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Maslak, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Difference in involved and uninvolved free light chain (dFLC) of less than 1mg/dL early post risk adapted melphalan and autologous stem cell transplantation (RA-ASCT) predicts renal response (RR) at 1 year in light chain (AL) amyloidosis
    Meeting Abstract

    Purvey, S.; Seier, K.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Hassoun, H.; Giralt, S. A.; Landau, H. J.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Difference in involved and uninvolved free light chain (dFLC) of less than 1mg/DL early post risk adapted melphalan and autologous stem cell transplantation (RA-ASCT) predicts renal response at 1 year in light chain (AL) amyloidosis
    Meeting Abstract

    Purvey, S.; Seier, K.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Hassoun, H.; Giralt, S. A.; Landau, H. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Efficacy of revaccination after autologous hematopoietic stem cell transplantation in lymphoma patients with or without rituximab exposure
    Meeting Abstract

    Preston, E. V.; Palazzo, M.; Seier, K.; Maloy, M. A.; Devlin, S. M.; Giralt, S. A.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Seier, K.; Devlin, S. M.; Chung, D. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Impact of pre-transplant rituximab on efficacy of revaccination of lymphoma patients after autologous hematopoietic stem cell transplantation
    Meeting Abstract

    Preston, E. V.; Palazzo, M. A.; Seier, K.; Devlin, S. M.; Giralt, S.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Toxicities associated with high dose chemotherapy and autologous stem cell transplantation in older patients with non-Hodgkin lymphoma
    Meeting Abstract

    Dahi, P. B.; Rondon Clavo, C.; Maloy, M.; Seier, K.; Devlin, S. M.; Robinson, K.; Scordo, M.; Shah, G. L.; Tamari, R.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save